AS-101
- Generic Name
- AS-101
Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients
- First Posted Date
- 2009-11-10
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01010373
- Locations
- 🇮🇱
Sheba Medical Center, Tel Hashomer, Israel
Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor Patients
- First Posted Date
- 2009-06-23
- Last Posted Date
- 2011-06-21
- Lead Sponsor
- BioMAS Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT00926354
- Locations
- 🇮🇱
Meir Medical Center, Kfar Saba, Israel
Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Phase 2
- Conditions
- Alopecia
- First Posted Date
- 2007-01-04
- Last Posted Date
- 2007-01-04
- Lead Sponsor
- Rabin Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00418249
A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Registration Number
- NCT00002033
- Locations
- 🇧🇷
Instituto Do Cancer Arnaldo Vieiro, Sao Paulo, Brazil
🇧🇷Escola Paulista De-Medicina, Sao Paulo, Brazil
🇧🇷Faculdade De-Ciencias Medica Da, Sao Paulo, Brazil
A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Registration Number
- NCT00002013
- Locations
- 🇺🇸
Los Angeles County - USC Med Ctr, Los Angeles, California, United States
An Open Parallel Study to Determine the Optimum Dosing Schedule for AS-101 in AIDS/ARC Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Registration Number
- NCT00002266
- Locations
- 🇺🇸
Univ of Arizona / Health Science Ctr, Tucson, Arizona, United States
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 30
- Registration Number
- NCT00001006
- Locations
- 🇺🇸
Mount Sinai Med Ctr, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath